» Articles » PMID: 35131900

Dark-field Computed Tomography Reaches the Human Scale

Abstract

X-ray computed tomography (CT) is one of the most commonly used three-dimensional medical imaging modalities today. It has been refined over several decades, with the most recent innovations including dual-energy and spectral photon-counting technologies. Nevertheless, it has been discovered that wave-optical contrast mechanisms-beyond the presently used X-ray attenuation-offer the potential of complementary information, particularly on otherwise unresolved tissue microstructure. One such approach is dark-field imaging, which has recently been introduced and already demonstrated significantly improved radiological benefit in small-animal models, especially for lung diseases. Until now, however, dark-field CT could not yet be translated to the human scale and has been restricted to benchtop and small-animal systems, with scan durations of several minutes or more. This is mainly because the adaption and upscaling to the mechanical complexity, speed, and size of a human CT scanner so far remained an unsolved challenge. Here, we now report the successful integration of a Talbot-Lau interferometer into a clinical CT gantry and present dark-field CT results of a human-sized anthropomorphic body phantom, reconstructed from a single rotation scan performed in 1 s. Moreover, we present our key hardware and software solutions to the previously unsolved roadblocks, which so far have kept dark-field CT from being translated from the optical bench into a rapidly rotating CT gantry, with all its associated challenges like vibrations, continuous rotation, and large field of view. This development enables clinical dark-field CT studies with human patients in the near future.

Citing Articles

Alpha-fetoprotein, glypican-3, and kininogen-1 as biomarkers for the diagnosis of hepatocellular carcinoma.

Dominguez-Lazcano D, Simon-Lara I, Morales-Romero J, Vasquez-Garzon V, Arroyo-Helguera O, Lopez-Vazquez J Int J Clin Exp Pathol. 2024; 17(11):383-395.

PMID: 39660335 PMC: 11626288. DOI: 10.62347/QSII4050.


T staging esophageal tumors with x rays.

Partridge T, Wolfson P, Jiang J, Massimi L, Astolfo A, Djurabekova N Optica. 2024; 11(4):569-576.

PMID: 39006164 PMC: 11239146. DOI: 10.1364/OPTICA.501948.


X-ray dark-field computed tomography for monitoring of tissue freezing.

John D, Gottwald W, Berthe D, Wirtensohn S, Hickler J, Heck L Sci Rep. 2024; 14(1):5599.

PMID: 38454107 PMC: 10920745. DOI: 10.1038/s41598-024-56201-3.


First experimental evaluation of a high-resolution deep silicon photon-counting sensor.

Brunskog R, Persson M, Jin Z, Danielsson M J Med Imaging (Bellingham). 2024; 11(1):013503.

PMID: 38314116 PMC: 10832234. DOI: 10.1117/1.JMI.11.1.013503.


Grating-based x-ray dark-field CT for lung cancer diagnosis in mice.

Guo P, Zhang L, Lu J, Zhang H, Zhu X, Wu C Eur Radiol Exp. 2024; 8(1):12.

PMID: 38270720 PMC: 10810771. DOI: 10.1186/s41747-023-00399-w.


References
1.
Weitkamp T, Diaz A, David C, Pfeiffer F, Stampanoni M, Cloetens P . X-ray phase imaging with a grating interferometer. Opt Express. 2009; 13(16):6296-304. DOI: 10.1364/opex.13.006296. View

2.
Zanette I, Bech M, Rack A, Le Duc G, Tafforeau P, David C . Trimodal low-dose X-ray tomography. Proc Natl Acad Sci U S A. 2012; 109(26):10199-204. PMC: 3387041. DOI: 10.1073/pnas.1117861109. View

3.
Yaroshenko A, Hellbach K, Yildirim A, Conlon T, Fernandez I, Bech M . Improved In vivo Assessment of Pulmonary Fibrosis in Mice using X-Ray Dark-Field Radiography. Sci Rep. 2015; 5:17492. PMC: 4664921. DOI: 10.1038/srep17492. View

4.
Velroyen A, Yaroshenko A, Hahn D, Fehringer A, Tapfer A, Muller M . Grating-based X-ray Dark-field Computed Tomography of Living Mice. EBioMedicine. 2015; 2(10):1500-6. PMC: 4634200. DOI: 10.1016/j.ebiom.2015.08.014. View

5.
Momose A . X-ray phase imaging reaching clinical uses. Phys Med. 2020; 79:93-102. DOI: 10.1016/j.ejmp.2020.11.003. View